Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-24-000072

EVP, Chief Business Officer sold 2,024 shares at $50.42 ($102,044)

  • EVP, Chief Business Officer acquired 5,041 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Baroldi Joseph · EVP, Chief Business Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-16 Exercise or conversion : show line 1 in the form +3,688 14,259 D
2024-01-17 Sale : show line 2 in the form −1,460 $50.42 $73,609 12,799 D
2024-01-16 Exercise or conversion : show line 3 in the form +1,353 2,204 I
2024-01-17 Sale : show line 4 in the form −564 $50.42 $28,435 1,640 I
Open-market sales · 2,024 sh · avg $50.42 · $102,044

Table II: Derivative

2 lines
Date Transaction Shares Exercise Underlying Owned after D/I
2024-01-16 Exercise or conversion : show line 5 in the form Restricted Stock Unit −3,688 $0.00 3,688 63,973 D
2024-01-16 Exercise or conversion : show line 6 in the form Restricted Stock Unit −1,353 $0.00 1,353 7,034 I
Loading xslF345X05/edgardoc.xml…